JERUSALEM — Israeli researchers have identified a genetic
"fingerprint" that helps predict the effectiveness of immunotherapy
treatments, according to a study.
The study, by the Israel Institute of Technology
(Technion), stated that the discovery would help improve the personalisation of
immunotherapy treatments, Xinhua news agency reported.
Immunotherapy is considered to be one of the greatest
revolutions in cancer treatment. It enhances the immune system’s ability to
target and destroy cancer cells efficiently.
However, a major challenge in immunotherapy is the
unpredictability of patient responses. Some patients do not benefit and may
experience side effects without significant improvement.
Therefore, there is a need to identify biomarkers that
can forecast the effectiveness of treatment based on the specific data of each
patient.
In their study, published in the journal Cell Genomics,
the team examined the genetic characteristics of T-cell clones -- groups of
multiplied immune T cells that specialise in targeting a specific threat once
recognised -- and their influence on treatment success.
To achieve the goal, the team conducted a large-scale
meta-analysis using single-cell RNA sequencing and T-cell receptor sequencing
data from cancer patients undergoing immunotherapy.
It was found that although these T-cell clones are
present in both responsive and non-responsive patients, those who respond to
immunotherapy display a distinct genetic signature in their T-cell clones, and
the treatment boosts their immune activity.
Another major finding was that in non-responsive
patients, some T-cell clones were simultaneously found both in the bloodstream
and the tumour.
To achieve a better immune response, it is crucial to
activating T-cell clones located solely within the tumour, rather than those
present in both the tumour and the bloodstream, the researchers said.
They added that this discovery will enhance predictive
capabilities and could lead to new treatment strategies that improve the
effectiveness of immunotherapy.